FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100304556> ?p ?o ?g. }

• W2100304556 endingPage "610.e11" @default.
• W2100304556 startingPage "602" @default.
• W2100304556 abstract "BackgroundHematopoietic stem cell transplantation remains the only treatment for most patients with severe combined immunodeficiencies (SCIDs) or other primary immunodeficiencies (non-SCID PIDs).ObjectiveTo analyze the long-term outcome of patients with SCID and non-SCID PID from European centers treated between 1968 and 2005.MethodsThe product-limit method estimated cumulative survival; the log-rank test compared survival between groups. A Cox proportional-hazard model evaluated the impact of independent predictors on patient survival.ResultsIn patients with SCID, survival with genoidentical donors (n = 25) from 2000 to 2005 was 90%. Survival using a mismatched relative (n = 96) has improved (66%), similar to that using an unrelated donor (n = 46; 69%; P = .005). Transplantation after year 1995, a younger age, B+ phenotype, genoidentical and phenoidentical donors, absence of respiratory impairment, or viral infection before transplantation were associated with better prognosis on multivariate analysis. For non-SCID PID, in contrast with patients with SCID, we confirm that, in the 2000 to 2005 period, using an unrelated donor (n = 124) gave a 3-year survival rate similar to a genoidentical donor (n = 73), 79% for both. Survival was 76% in phenoidentical transplants (n = 23) and worse in mismatched related donor transplants (n = 47; 46%; P = .016).ConclusionThis is the largest cohort study of such patients with the longest follow-up. Specific issues arise for different patient groups. Patients with B-SCID have worse survival than other patients with SCID, despite improvements in each group. For non-SCID PID, survival is worse than SCID, although more conditions are now treated. Individual disease categories now need to be analyzed so that disease-specific prognosis may be better understood and the best treatments planned. Hematopoietic stem cell transplantation remains the only treatment for most patients with severe combined immunodeficiencies (SCIDs) or other primary immunodeficiencies (non-SCID PIDs). To analyze the long-term outcome of patients with SCID and non-SCID PID from European centers treated between 1968 and 2005. The product-limit method estimated cumulative survival; the log-rank test compared survival between groups. A Cox proportional-hazard model evaluated the impact of independent predictors on patient survival. In patients with SCID, survival with genoidentical donors (n = 25) from 2000 to 2005 was 90%. Survival using a mismatched relative (n = 96) has improved (66%), similar to that using an unrelated donor (n = 46; 69%; P = .005). Transplantation after year 1995, a younger age, B+ phenotype, genoidentical and phenoidentical donors, absence of respiratory impairment, or viral infection before transplantation were associated with better prognosis on multivariate analysis. For non-SCID PID, in contrast with patients with SCID, we confirm that, in the 2000 to 2005 period, using an unrelated donor (n = 124) gave a 3-year survival rate similar to a genoidentical donor (n = 73), 79% for both. Survival was 76% in phenoidentical transplants (n = 23) and worse in mismatched related donor transplants (n = 47; 46%; P = .016). This is the largest cohort study of such patients with the longest follow-up. Specific issues arise for different patient groups. Patients with B-SCID have worse survival than other patients with SCID, despite improvements in each group. For non-SCID PID, survival is worse than SCID, although more conditions are now treated. Individual disease categories now need to be analyzed so that disease-specific prognosis may be better understood and the best treatments planned." @default.
• W2100304556 created "2016-06-24" @default.
• W2100304556 creator A5006102363 @default.
• W2100304556 creator A5007387587 @default.
• W2100304556 creator A5009833524 @default.
• W2100304556 creator A5013983797 @default.
• W2100304556 creator A5014207275 @default.
• W2100304556 creator A5014990865 @default.
• W2100304556 creator A5016105550 @default.
• W2100304556 creator A5026927916 @default.
• W2100304556 creator A5029004287 @default.
• W2100304556 creator A5029163913 @default.
• W2100304556 creator A5031071122 @default.
• W2100304556 creator A5041198701 @default.
• W2100304556 creator A5041681218 @default.
• W2100304556 creator A5051621566 @default.
• W2100304556 creator A5054904756 @default.
• W2100304556 creator A5055180780 @default.
• W2100304556 creator A5057471061 @default.
• W2100304556 creator A5061463272 @default.
• W2100304556 creator A5072838648 @default.
• W2100304556 creator A5073001580 @default.
• W2100304556 creator A5073776230 @default.
• W2100304556 creator A5075839647 @default.
• W2100304556 creator A5076169728 @default.
• W2100304556 creator A5081973009 @default.
• W2100304556 creator A5090000319 @default.
• W2100304556 creator A5090793182 @default.
• W2100304556 date "2010-09-01" @default.
• W2100304556 modified "2023-10-15" @default.
• W2100304556 title "Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?" @default.
• W2100304556 cites W1537303659 @default.
• W2100304556 cites W1970788402 @default.
• W2100304556 cites W1981881077 @default.
• W2100304556 cites W1992938702 @default.
• W2100304556 cites W2006725662 @default.
• W2100304556 cites W2007491974 @default.
• W2100304556 cites W2012752335 @default.
• W2100304556 cites W2017464398 @default.
• W2100304556 cites W2017837324 @default.
• W2100304556 cites W2022738484 @default.
• W2100304556 cites W2035594809 @default.
• W2100304556 cites W2041343788 @default.
• W2100304556 cites W2045074827 @default.
• W2100304556 cites W2045705588 @default.
• W2100304556 cites W2048279530 @default.
• W2100304556 cites W2051071539 @default.
• W2100304556 cites W2052538378 @default.
• W2100304556 cites W2056313519 @default.
• W2100304556 cites W2056583919 @default.
• W2100304556 cites W2060075862 @default.
• W2100304556 cites W2074477988 @default.
• W2100304556 cites W2077324183 @default.
• W2100304556 cites W2082066722 @default.
• W2100304556 cites W2084901609 @default.
• W2100304556 cites W2088882275 @default.
• W2100304556 cites W2089184630 @default.
• W2100304556 cites W2090582369 @default.
• W2100304556 cites W2113448947 @default.
• W2100304556 cites W2115016218 @default.
• W2100304556 cites W2122393335 @default.
• W2100304556 cites W2129413349 @default.
• W2100304556 cites W2130113751 @default.
• W2100304556 cites W2145036599 @default.
• W2100304556 cites W2148629244 @default.
• W2100304556 cites W2152461163 @default.
• W2100304556 cites W2170677852 @default.
• W2100304556 cites W2172137324 @default.
• W2100304556 cites W2330288813 @default.
• W2100304556 doi "https://doi.org/10.1016/j.jaci.2010.06.015" @default.
• W2100304556 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20673987" @default.
• W2100304556 hasPublicationYear "2010" @default.
• W2100304556 type Work @default.
• W2100304556 sameAs 2100304556 @default.
• W2100304556 citedByCount "360" @default.
• W2100304556 countsByYear W21003045562012 @default.
• W2100304556 countsByYear W21003045562013 @default.
• W2100304556 countsByYear W21003045562014 @default.
• W2100304556 countsByYear W21003045562015 @default.
• W2100304556 countsByYear W21003045562016 @default.
• W2100304556 countsByYear W21003045562017 @default.
• W2100304556 countsByYear W21003045562018 @default.
• W2100304556 countsByYear W21003045562019 @default.
• W2100304556 countsByYear W21003045562020 @default.
• W2100304556 countsByYear W21003045562021 @default.
• W2100304556 countsByYear W21003045562022 @default.
• W2100304556 countsByYear W21003045562023 @default.
• W2100304556 crossrefType "journal-article" @default.
• W2100304556 hasAuthorship W2100304556A5006102363 @default.
• W2100304556 hasAuthorship W2100304556A5007387587 @default.
• W2100304556 hasAuthorship W2100304556A5009833524 @default.
• W2100304556 hasAuthorship W2100304556A5013983797 @default.
• W2100304556 hasAuthorship W2100304556A5014207275 @default.
• W2100304556 hasAuthorship W2100304556A5014990865 @default.
• W2100304556 hasAuthorship W2100304556A5016105550 @default.
• W2100304556 hasAuthorship W2100304556A5026927916 @default.
• W2100304556 hasAuthorship W2100304556A5029004287 @default.
• W2100304556 hasAuthorship W2100304556A5029163913 @default.

• next